Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of GC4419 on Dextromethorphan Pharmacokinetics
NCT03792971Phase 1Completed
- Sponsor
- Galera Therapeutics, Inc.
- Start
- Feb 2019
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of avasopasem manganese in oral mucositis (OM), sponsored by Galera Therapeutics, Inc. Primary endpoints: Area Under the Curve from time zero to last measurable concentration, Area Under the Curve from time zero to infinity and 1 more. Started Feb 2019; status: completed.
02
Drugs
avasopasem manganese
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03792971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792971.